SYKTICKER
Stryker Corp.
Congress has disclosed 34 buys and 52 sells of SYK (Stryker Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
34
Buy
52
Sell
-18
Net
18
Active politicians
Round-trip watch Still on the books
Members who disclosed buying SYK and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Gilbert Cisneros | 2025-12-10 | $349.92 | $295.63 | -15.5% | underwater |
| Rohit Khanna | 2026-04-13 | $345.22 | $295.63 | -14.4% | underwater |
| Jared Moskowitz | 2025-04-07 | $340.05 | $295.63 | -13.1% | underwater |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
31.06
≈ in line with
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$295.63 ÷ $9.52 = 31.06
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.8
≈ in line with
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$295.63 ÷ $61.62 = 4.8
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
17.74
≈ in line with
Health (median 16.2)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($112.5B + $11.7B net debt) ÷ $7.0B = $124.2B ÷ $7.0B = 17.74
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
87 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2026-09-30 | 7 days | 0.0% | $1K–$15K 0.1% of NW |
95.9 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2026-07-22 | 16 days | +9.6% | $1K–$15K 0.1% of NW |
69.0 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence | Self · State Street Bank & Trust Co. | 2026-06-02 | 16 days | +4.9% | $1K–$15K 0.1% of NW |
64.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Spouse | 2026-04-13 | 21 days | -16.2% | $15K–$50K | 25.1 | ↗ filing |
| Alan Armstrong | Senate | OTHER | Self | 2026-03-27 | 116 days | -3.4% | $15K–$50K | 99.6 | ↗ eFD |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-02-24 | 8 days | +0.1% | $15K–$50K | 19.2 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence | Self · State Street Bank & Trust Co. | 2026-01-23 | 13 days | +2.1% | $15K–$50K 0.3% of NW |
67.4 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2025-12-10 | 30 days | +4.1% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2025-11-20 | 15 days | +1.0% | $15K–$50K 0.3% of NW |
68.9 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | -1.5% | $1K–$15K 0.1% of NW |
13.7 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2025-10-17 | 26 days | -1.9% | $1K–$15K 0.1% of NW |
27.5 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider convergence · moderate | Self · Merrill Lynch Investment Account #025 | 2025-10-16 | 16 days | -3.5% | $1K–$15K 1.0% of NW |
32.4 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2025-09-12 | 7 days | -1.7% | $15K–$50K 0.3% of NW |
69.1 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2025-08-25 | 15 days | +0.5% | $1K–$15K 0.1% of NW |
63.1 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2025-07-31 | 7 days | -4.2% | $15K–$50K 0.3% of NW |
82.7 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | +1.1% | $50K–$100K <0.1% of NW |
53.3 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-04-17 | 8 days | +5.4% | $15K–$50K <0.1% of NW |
84.7 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-04-07 | 23 days | +8.3% | $1K–$15K 0.3% of NW |
25.2 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Child · Morgan Stanley Active Assets (5) | 2025-01-15 | 16 days | +6.2% | $1K–$15K 0.3% of NW |
64.6 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Child · Morgan Stanley Active Assets (6) | 2025-01-15 | 16 days | +6.2% | $1K–$15K 0.3% of NW |
64.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-12-19 | 19 days | -0.3% | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-12-17 | 21 days | -4.0% | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-12-05 | 33 days | -6.9% | $1K–$15K | 2.6 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider divergence · moderate | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | +4.4% | $1K–$15K 1.0% of NW |
69.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-10-14 | 24 days | +2.8% | $1K–$15K | 12.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-09-13 | 19 days | -4.2% | $1K–$15K | 4.5 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-04-15 | 16 days | — | $1K–$15K | 5.5 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence · moderate | Child | 2024-03-22 | 12 days | — | $1K–$15K | 6.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-01-10 | 23 days | — | $1K–$15K | 8.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-11-03 | 32 days | — | $1K–$15K | 10.6 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence · moderate | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-10-17 | 20 days | — | $1K–$15K | 26.5 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence · moderate | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-05-10 | 23 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-04-12 | 21 days | — | $1K–$15K | 52.4 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence · moderate | Self | 2023-03-17 | 4 days | — | $15K–$50K 0.7% of NW |
48.5 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2023-02-24 | 10 days | — | $15K–$50K 0.3% of NW |
96.9 | ↗ filing |
| Michael Burgess | House | BUY ◆ insider divergence · moderate | Self | 2023-02-24 | 4 days | — | $1K–$15K 0.2% of NW |
12.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2023-02-15 | 14 days | — | $1K–$15K | 86.8 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2023-01-27 | 6 days | — | $15K–$50K 0.3% of NW |
98.1 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · State Street Bank & Trust Co. | 2023-01-10 | 21 days | — | $15K–$50K 0.3% of NW |
99.8 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence · moderate | Spouse | 2023-01-03 | 0 days | — | $100K–$250K 3.8% of NW 🔥 |
54.5 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence · moderate | Self | 2022-12-30 | 5 days | — | $100K–$250K 3.8% of NW 🔥 |
54.5 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider divergence · moderate | Self | 2022-11-29 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider divergence · moderate | Spouse | 2022-11-28 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider divergence · moderate | Self | 2022-10-25 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider divergence · moderate | Spouse | 2022-10-24 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-08-31 | 0 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-07-22 | 0 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2022-07-22 | 3 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-06-21 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2022-05-24 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-05-23 | 0 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-04-18 | 2 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2022-04-18 | 1 days | — | $1K–$15K 0.2% of NW |
2.6 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2022-03-21 | 1 days | — | $1K–$15K 0.2% of NW |
5.5 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-03-21 | 1 days | — | $1K–$15K 0.2% of NW |
5.5 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2022-02-23 | 1 days | — | $1K–$15K 0.2% of NW |
6.8 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2022-01-27 | 1 days | — | $1K–$15K 0.2% of NW |
8.6 | ↗ filing |
| Rick Larsen | House | BUY | Self · Richard R Larsen IRA > Ameriprise SPS Managed Account | 2022-01-06 | 497 days | — | $1K–$15K 0.7% of NW |
75.9 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2021-12-21 | 1 days | — | $1K–$15K 0.2% of NW |
15.7 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2021-12-21 | 1 days | — | $1K–$15K 0.2% of NW |
15.7 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2021-11-23 | 17 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Michael Burgess | House | SELL | Spouse | 2021-10-19 | 0 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Michael Burgess | House | SELL | Self | 2021-10-14 | 1 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-09-16 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Cindy Axne | House | BUY ◆ insider convergence · moderate | Self | 2020-07-17 | 437 days | — | $1K–$15K | 22.3 | ↗ filing |
| Cindy Axne | House | BUY ◆ insider convergence · moderate | Spouse | 2020-07-17 | 437 days | — | $1K–$15K | 22.3 | ↗ filing |
| Cindy Axne | House | BUY ◆ insider convergence · moderate | Spouse | 2020-07-13 | 441 days | — | $1K–$15K | 40.4 | ↗ filing |
| Cindy Axne | House | BUY | Spouse | 2019-12-31 | 636 days | — | $1K–$15K | 75.9 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-01-04 | 32 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2018-11-21 | 5 days | — | $1K–$15K | 15.7 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-04-23 | 2 days | — | $1K–$15K | 31.8 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2018-04-23 | 8 days | — | $1K–$15K | 52.4 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2018-04-13 | 18 days | — | $1K–$15K | 86.8 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2018-02-26 | 2 days | — | $1K–$15K | 75.9 | ↗ filing |
| Michael Conaway | House | BUY | Self | 2018-02-26 | 2 days | — | $1K–$15K | 75.9 | ↗ filing |
| Scott Peters | House | SELL | Spouse | 2015-09-02 | 0 days | — | $50K–$100K 0.2% of NW |
97.0 | ↗ filing |
| Rubén Hinojosa | House | SELL | Spouse | 2015-08-21 | 0 days | — | $1K–$15K | 52.4 | ↗ filing |
| Scott Peters | House | BUY | Spouse | 2015-07-10 | 21 days | — | $15K–$50K 0.1% of NW |
96.9 | ↗ filing |
| Scott Peters | House | BUY | Spouse | 2015-06-26 | 4 days | — | $15K–$50K 0.1% of NW |
98.1 | ↗ filing |
| Rubén Hinojosa | House | BUY | Spouse | 2015-06-24 | 0 days | — | $1K–$15K | 86.8 | ↗ filing |
| Scott Peters | House | BUY | Spouse | 2015-06-23 | 7 days | — | $15K–$50K 0.1% of NW |
99.8 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2015-05-28 | 13 days | — | $1K–$15K | 40.4 | ↗ filing |
| Richard Hanna | House | BUY | Self | 2015-03-03 | 38 days | — | $50K–$100K | 94.3 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2014-06-16 | 23 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in SYK — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
28
Congress trades with insider convergence
22
…with insider divergence
207
Insider open-market trades
Of the congressional trades in SYK, 28 coincided with corporate insiders moving the same way within 60 days, and 22 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-21 | Crotty Dylan Bram | C-suite | SELL | $145K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $13K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $147K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $67K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $27K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $108K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $780K | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $3.8M | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $3.7M | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $5.7M | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $1.1M | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $1.3M | ↗ EDGAR |
| 2026-08-19 | STRYKER RONDA E | Director | SELL | $276K | ↗ EDGAR |
| 2026-08-18 | King Debra | Other | SELL | $278K | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $743K | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $971K | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $2.8M | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $8.6M | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $44.2M | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $36.8M | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $5.5M | ↗ EDGAR |
| 2026-08-18 | STRYKER RONDA E | Director | SELL | $1.2M | ↗ EDGAR |
| 2026-05-28 | Fletcher Robert S | C-suite | SELL 10b5-1 | $37K | ↗ EDGAR |
| 2026-05-28 | Fletcher Robert S | C-suite | SELL 10b5-1 | $50K | ↗ EDGAR |
| 2026-05-28 | Fletcher Robert S | C-suite | SELL 10b5-1 | $861K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-30 | Thomas Kean | SELL | $1K–$15K |
| ◆ insider | 2026-08-21 | Crotty Dylan Bram C-suite | SELL | $145K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $13K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $147K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $67K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $27K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $108K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $780K |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $3.8M |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $3.7M |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $5.7M |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $1.1M |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $1.3M |
| ◆ insider | 2026-08-19 | STRYKER RONDA E Director | SELL | $276K |
| ◆ insider | 2026-08-18 | King Debra Other | SELL | $278K |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $743K |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $971K |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $2.8M |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $8.6M |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $44.2M |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $36.8M |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $5.5M |
| ◆ insider | 2026-08-18 | STRYKER RONDA E Director | SELL | $1.2M |
| Congress | 2026-07-22 | Thomas Kean | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded SYK?
34 disclosed buys and 52 sells of SYK (Stryker Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade SYK?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.